Gary H. Lyman

Active 1976–2025

Also published as
Gary H, Lyman
225
Papers
68,638
Citations
127
h-index
220
i10-index

Citations

Citations per year for Gary H. Lyman1967: 1 citations1974: 1 citations1977: 3 citations1978: 4 citations1979: 4 citations1980: 5 citations1981: 1 citations1982: 1 citations1984: 2 citations1985: 1 citations1987: 2 citations1988: 3 citations1989: 15 citations1990: 15 citations1991: 16 citations1992: 30 citations1993: 28 citations1994: 30 citations1995: 26 citations1996: 42 citations1997: 52 citations1998: 62 citations1999: 88 citations2000: 145 citations2001: 133 citations2002: 167 citations2003: 201 citations2004: 196 citations2005: 224 citations2006: 213 citations2007: 323 citations2008: 306 citations2009: 359 citations2010: 355 citations2011: 320 citations2012: 371 citations2013: 387 citations2014: 302 citations2015: 403 citations2016: 373 citations2017: 395 citations2018: 371 citations2019: 1,577 citations2020: 1,995 citations2021: 1,930 citations2022: 1,339 citations2023: 866 citations2024: 1,397 citations2025: 478 citations2026: 25 citations1968–1973: no citations, so these years are not shown1975–1976: no citations, so these years are not shown1983: no citations, so this year is not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,343 citing papers, 28.1% of this breakdownUnited Kingdom: 1,271 citing papers, 6.7% of this breakdownItaly: 1,108 citing papers, 5.8% of this breakdownCanada: 1,085 citing papers, 5.7% of this breakdownChina: 1,027 citing papers, 5.4% of this breakdownGermany: 913 citing papers, 4.8% of this breakdownFrance: 801 citing papers, 4.2% of this breakdownNetherlands: 732 citing papers, 3.9% of this breakdownSpain: 550 citing papers, 2.9% of this breakdownAustralia: 533 citing papers, 2.8% of this breakdownJapan: 457 citing papers, 2.4% of this breakdownSwitzerland: 451 citing papers, 2.4% of this breakdown
0%28.1%Other 24.9%

Fields

  • Medicine76.3%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology2.2%
  • Economics, Econometrics and Finance1.6%
  • Computer Science1%
  • Health Professions1%
  • Other4.7%

Topics

  • Venous Thromboembolism Diagnosis and Management4.4%
  • Cancer survivorship and care3.5%
  • Breast Cancer Treatment Studies3.2%
  • Neutropenia and Cancer Infections2.1%
  • Cutaneous Melanoma Detection and Management2%
  • COVID-19 and healthcare impacts1.8%
  • Other83%

Coauthors

All papers

Open in search
  1. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

    Authors: , , , , , , , , , , , , , , , - Blood Advances 2021 cited by 849

  2. Development and validation of a predictive model for chemotherapy-associated thrombosis

    Authors: , , , , - Blood 2008 cited by 2,201

  3. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 1,475

  4. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

    Authors: , , , , - Journal of Thrombosis and Haemostasis 2007 cited by 1,669

  5. Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

    Authors: , , , , - Nature Reviews Clinical Oncology 2023 cited by 279

  6. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 1,326

  7. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 317

  8. Antiemetics: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 457

  9. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 714

  10. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

    Authors: , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2015 cited by 1,033

  11. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 332

  12. Mitigating acute chemotherapy-associated adverse events in patients with cancer

    Authors: , , , - Nature Reviews Clinical Oncology 2022 cited by 153

  13. Recommendations on the Use of 18F-FDG PET in Oncology

    Authors: , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2008 cited by 1,089

  14. American Cancer Society Head and Neck Cancer Survivorship Care Guideline

    Authors: , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2016 cited by 607

  15. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 415

  16. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States

    Authors: , , , , , - BMC Cancer 2018 cited by 378

  17. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 905

  18. Chemotherapy‐induced neutropenia

    Authors: , , - Cancer 2004 cited by 875

  19. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: , , , , , - Journal of Clinical Oncology 2017 cited by 591

  20. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 903

  21. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 1,893

  22. Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score

    Authors: , , , , , , , , , , - Cancer 2011 cited by 1,143

  23. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 1,029

  24. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony P. Gulati, Shilpa Gupta, Navid Hafez, Þorvarður R. Hálfdánarson, Jessica E. Hawley, Emily Hsu, Anup Kasi, Ali Raza Khaki, Christopher A. Lemmon, Colleen Lewis, Barbara Logan, Tyler Masters, Rana R. McKay, Ruben A. Mesa, Alicia K. Morgans, Mary F. Mulcahy, Orestis A. Panagiotou, Prakash Peddi, Nathan A. Pennell, Kerry L. Reynolds, L Rosen, Rachel Rosovsky, Mary Salazar, Andrew Schmidt, Sumit Shah, Justin Shaya, John A. Steinharter, Keith Stockerl‐Goldstein, Suki Subbiah, Donald C. Vinh, Firas Wehbe, Lisa B. Weissmann, Julie Wu, Elizabeth Wulff‐Burchfield, Zhuoer Xie, Albert C. Yeh, Peter Paul Yu, Alice Y. Zhou, Leyre Zubiri, Sanjay Mishra, Gary H. Lyman, Brian I. Rini, Jeremy L. Warner, Maheen Z. Abidi, Jared D. Acoba, Neeraj Agarwal, Syed A. Ahmad, Archana Ajmera, Jessica K. Altman, Anne H. Angevine, Nilo Azad, Michael Bär, Aditya Bardia, Jill S. Barnholtz‐Sloan, Briana Barrow, Babar Bashir, Rimma Belenkaya, Stephanie Berg, Eric Bernicker, Christine M. Bestvina, Rohit Bishnoi, Genevieve M. Boland, Mark Bonnen, Gabrielle Bouchard, Daniel W. Bowles, Fiona Busser, Angelo Cabal, Paolo F. Caimi, Theresa M. Carducci, Carla Casulo and 136 more - The Lancet 2020 cited by 1,802